Jul 8, 2026 06:41AM
Jun 11, 2026 04:23AM
May 4, 2026 04:30PM
Mar 17, 2026 07:12AM
Feb 12, 2026 04:30PM
Dec 21, 2025 04:00AM
Dec 16, 2025 12:00PM From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
Dec 9, 2025 11:57AM
Nov 19, 2025 10:06AM
Nov 10, 2025 08:00AM
Oct 31, 2025 09:54AM
Oct 24, 2025 08:29AM
Aug 4, 2025 04:15PM
May 6, 2025 04:01PM CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3
Apr 11, 2025 05:04AM
Apr 4, 2025 01:08PM
Feb 11, 2025 04:01PM
Jan 13, 2025 07:01AM
Jan 13, 2025 07:00AM
Jan 4, 2025 04:00PM
Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 9, 2024 12:01PM
Dec 9, 2024 12:00PM
Jan 16, 2024 04:01PM
Jan 16, 2024 04:01PM
Jan 8, 2024 07:07AM
Jan 8, 2024 07:00AM
Dec 8, 2023 12:55PM Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™
Dec 8, 2023 12:52PM
Dec 8, 2023 12:09PM
Dec 8, 2023 12:05PM
Dec 8, 2023 11:51AM
Dec 8, 2023 11:20AM
Nov 16, 2023 04:53AM
Nov 16, 2023 01:45AM  Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell
Nov 6, 2023 04:15PM
Nov 1, 2023 05:47AM
Oct 31, 2023 05:53PM
Oct 31, 2023 07:10AM
Oct 31, 2023 07:05AM
Aug 7, 2023 04:01PM
Jun 9, 2023 05:35AM Vertex Pharma (VRTX) Announces FDA Acceptance of BLA for exagamglogene autotemcel for Severe Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia
Jun 9, 2023 05:29AM
Jun 9, 2023 03:01AM
Jun 8, 2023 07:23PM
May 8, 2023 04:01PM
Apr 3, 2023 08:01AM
Apr 3, 2023 08:00AM
Feb 21, 2023 04:01PM CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
Dec 12, 2022 10:00AM

325,893 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All